Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityLong-Term InvestmentsNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - AccuredReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bain Capital Specialty Finance (BCSF) Cash & Equivalents (2021 - 2026)

Bain Capital Specialty Finance has reported Cash & Equivalents over the past 6 years, most recently at $13.6 million for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 33.66% year-over-year to $13.6 million; the TTM value through Mar 2026 reached $13.6 million, up 33.66%, while the annual FY2025 figure was $38.8 million, 62.53% down from the prior year.
  • Cash & Equivalents for Q1 2026 was $13.6 million at Bain Capital Specialty Finance, down from $38.8 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $128.6 million in Q2 2023 and troughed at $10.2 million in Q1 2025.
  • A 5-year average of $57.7 million and a median of $40.9 million in 2025 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 305.89% in 2024 and later crashed 89.14% in 2025.
  • Year by year, Cash & Equivalents stood at $125.7 million in 2022, then plummeted by 65.8% to $43.0 million in 2023, then soared by 140.92% to $103.6 million in 2024, then plummeted by 62.53% to $38.8 million in 2025, then crashed by 64.98% to $13.6 million in 2026.
  • Business Quant data shows Cash & Equivalents for BCSF at $13.6 million in Q1 2026, $38.8 million in Q4 2025, and $40.9 million in Q3 2025.